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CFTR was reported to regulate ENaC channel opening, decreasing ENaC activity in airways and increasing it in sweat ducts. We
generated MDCK-I cell lines stably expressing tagged αβγENaC+CFTR or ENaC alone, and developed an assay to quantify cell-surface
half-life of ENaC. Surprisingly, we found that co-expressed CFTR stabilizes ENaC at the plasma membrane, suggesting that CFTR regulates
ENaC stability, not just opening.
© 2007 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Epithelial Na+ channel; Cystic fibrosis conductance regulator; Half-life1. Introduction
Numerous studies have documented the inhibition of
ENaC by CFTR in NIH-3T3 fibroblasts, MDCK epithelial
cells [1–3], Xenopus oocytes [4–7] and in native cells and
tissues, such as A6 cells [8], mouse cortical collecting duct
cells [9], airway (nasal) epithelia [10] and colon tissue
[11,12]. Moreover, ENaC inhibition is not exerted by CFTR
bearing common CF mutations (ΔF508, G551D) [4,13]. In
contrast, unlike airway or colonic epithelia, ENaC activity is
dependent on and increases with CFTR activity in sweat
ducts, which comprise purely absorptive epithelia [14,15].
The mechanism for the inhibition of ENaC activity by CFTR
in the airways is not clear but was proposed to involve cAMP
and to affect ENaC channel opening (Po), not numbers [2,7].
Since cell surface stability of ENaC is a major
determinant of its regulation [16], we investigated the
possible role of CFTR in this regulation by generating stable
epithelial MDCK-I cell lines that express tagged ENaC or
ENaC+CFTR (including an myc tag at the ectodomain of
ENaC), and developing an ELISA-type assay to quantify cell
surface ENaC expression. We show here that ENaC is⁎ Corresponding author. Tel.: +1 416 813 5098; fax: +1 416 813 5771.
E-mail address: drotin@sickkids.ca (D. Rotin).
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doi:10.1016/j.jcf.2007.03.001stabilized at the plasma membrane upon co-expression of
CFTR.
2. Methods
2.1. Cell lines generation, CFTR and ENaC expression and
activity
Generation of the stable MDCK-I cell line expressing
epitope tagged αβγENaC (Fig. 1A) was described pre-
viously [17]. CFTR C-terminally tagged with VSVG (kindly
provided by M. Buchwald) was stably transfected into the
above ENaC expressing cells to generate the ENaC+CFTR
cell line (Fig. 1). Briefly, full-length CFTR-VSVG was
cloned into pcDNA3.1/Zeo (Invitrogen). The plasmid was
stably transfected into the above ENaC-expressing cell line
with Lipofactamine 2000 (Invitrogen). The transfected cells
were selected under 5 μg/ml of Zeocin, and surviving clones
tested for expression of CFTR and ENaC with antibodies to
their respective tags, as well as anti-CFTR monoclonal
antibodies (Roche). Channel activity of both channels was
assessed by Short Circuit current (Ussing chamber) (Fig. 1),
as well as by earlier patch clamp analysis for ENaC activity
[17]. For Ussing chambers, we followed a previously
published protocol [18]. Briefly, ENaC or ENaC+CFTR
expressing MDCK-I cells were grown to confluency oned by Elsevier B.V. All rights reserved.
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(World Precision Instruments), and both sides of cell-
monolayers were bathed in 37 °C Hank's balanced salt
solution (Wisent Inc.) supplemented with 1 mM CaCl2,Fig. 1. Characterization of the stable αβγENaC and αβγENaC+CFTR expressi
depicting their intracellular epitope tags and the myc tag at the ectodomain of ENaC
analyzed by immunoblotting. For CFTR: immunoblotting was carried out with ant
antibodies to tags on the channel subunits were used (anti HA, anti-myc or anti Flag
SDS-PAGE (prior to immunoblotting) was 150 μg for α or βENaC, and 800 μg for
ISC measurements of ENaC and CFTR activity by Ussing chambers. Cells were gro
the membrane contained 140 mM Na+. Amiloride (Amil, 10 μM) and forskolin (5
(100 μM), or GlyH101 (25 μM, not shown), known inhibitors of CFTR, was
Mean±SEM of 3 separate experiments is shown.1 mM MgCl and 21 mM NaHCO3, and equilibrated with a
5% CO2/95% O2 gas mixture. Transepithelial short-circuit
current (ISC, μA/cm
2) was determined using a voltage–
current clamp (Physiologic Instruments). The amiloride-ng MDCK-I cell lines. (A) Schematic representation of ENaC and CFTR,
. (B) Expression of ENaC and CFTR in the αβγENaC+CFTRMDCK-I cells
ibodies to the VSVG tag or with anti CFTR antibodies (m3A07). For ENaC:
, to detect, α, β, or γ ENaC, respectively). The amount of protein used for the
γENaC, since γENaC expression is much weaker. ⁎=non-specific band. (C)
wn on permeable filter support until confluent. The medium on both sides of
0 μM) plus IBMX (100 μM) (F/I) were added apically. CFTR inhibitor 172
added (apically) to inhibit the F/I-mediated stimulation of CFTR activity.
421C. Lu et al. / Journal of Cystic Fibrosis 6 (2007) 419–422sensitive (ENaC) ISC was determined by exposing the apical
side of the monolayers to 10 μM amiloride and CFTR
activity was stimulated with forskolin (50 μM) plus IBMX
(100 μM) (F/I) added apically, or inhibited with the CFTR
inhibitor 172 (100 μM, Calbiochem).
2.2. ELISA
To quantify cell surface ENaC, an ELISA-type assay was
developed, using anti-myc antibodies, which recognize the
myc tag at the ectodomain of ENaC (Fig. 1A), as detailed
elsewhere [19]. Briefly, cells were treated with cyclohximide
(CHX, 44.4 μM in DMSO) for the indicated times and were
then surface-labeled with anti-myc antibodies (UBI, 1:100)
at 4 °C. They were subsequently fixed in 3% PFA.
Peroxidase-conjugated F(ab')2 fragment (1:1000 dilution)
was then added, and following incubation, cells were washed
extensively with PBS. For quantitation of cell-surface ENaC,
a chemiluminescent assay was employed, using SuperSignal
ELISA Pico Chemiluminescent Substrate (as per manufac-
turer instructions). Chemiluminescence was quantified using
Microplate Luminometer LB 96 V (EG&G Berthold).
3. Results and discussion
To investigate the possible role of CFTR in regulating
ENaC stability (half-life) at the plasma membrane, we stably
introduced VSVG-tagged CFTR into MDCK-I cells that
stably express tagged αβγENaC (described previously [17])
(Fig. 1A). The expression of the ENaC subunits in the ENaC-
expressing cells (ENaC alone or ENaC+CFTR) is depictedFig. 2. Cell surface stability of ENaC in the presence/absence of co-expressed CFT
MDCK-I cells stably expressing ENaC or ENaC+CFTR, in the presence of CHX (
life (starting from 60 min after the addition of CHX, to ensure complete blockade o
the myc tag at the ectodomain of ENaC. Data points represent mean±SD of 5–6 s
experiments). Dotted line delineates the half-life (108 min) of cell surface ENaC win Fig. 1B. Fig. 1B also shows that the ENaC+CFTR cells
also express CFTR, and both ENaC and CFTR are active,
as determined by ISC in Ussing chambers (Fig. 1C) and by
Cl−/I− flux assays (not shown).
To determine the half-life of ENaC at the plasma
membrane, we treated ENaC or ENaC+CFTR cells with
cycloheximide (CHX) to block protein synthesis and thus the
arrival of newly synthesized channels to the plasma
membrane (BrefeldinA is not effective in MDCK cells,
[20]) in the presence of amiloride, and then used an ELISA-
type assay to quantify the amounts of ENaC at the cell
surface over time by staining live (non-permeabilized) cells
with myc antibodies [19]. As seen in Fig. 2, ENaC dis-
appeared from the plasma membrane relatively quickly
(half-life ∼1.5 h). In contrast, upon co-expression of CFTR
in the same cells, ENaC was stabilized at the plasma
membrane, with 100% ENaC remaining at the plasma
membrane for at least 10 h (Fig. 2). Longer incubation
periods were not attempted due to concerns over the
toxic effect of prolonged exposure of cells to CHX. These
ENaC+CFTR cells express high levels of CFTR and low
levels of ENaC. Interestingly, in a separate MDCK-I cell
line we generated subsequently, which expresses low levels
of CFTR and high levels of ENaC, we found only a small
effect (1.2-fold increase in half-life) of CFTR on stabiliza-
tion of ENaC at the cell surface (not shown). This suggests
that the effect of CFTR on stabilizing ENaC is dose-
dependent.
Our work described here points to the regulation of the
number of ENaC channels by CFTR, in agreement with
earlier work of Duszyk et al. [21], but different from otherR. Time course of disappearance of ENaC from the cell surface of polarized
44 μM) and Amiloride (10 μM). Inset: calculation of ENaC cell surface half-
f protein synthesis). Cell surface expression was analyzed with antibodies to
eparate experiments, each performed in 3–8 replicates (6 replicates in most
hen expressed alone (inset).
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not numbers [2,7]. Until now, however, there have not been
any studies published that measure the half-life of cell
surface ENaC expressed in polarized epithelial cells in the
presence of CFTR, hence it is difficult to directly compare our
results to those of others (e.g. [7]). While our studies were
carried out in the absence of cAMP-mediated stimulation of
CFTR, it is likely that basal activity of CFTR, which is highly
expressed in these transfected cells, still allows for a
substantial Cl− conductance. Cl− transport per se was pro-
posed as a mechanism to explain CFTR-mediated regulation
of ENaC activity [22–24]. Given that at steady-state, total
cellular levels and cell surface expression of ENaC are the
same between the ENaC-alone and ENaC+CFTR expressing
cells (Fig. 1B and data not shown), the observed more positive
basal membrane potential and smaller effect of amiloride in the
ENaC+CFTR cells (Fig. 1C, middle) relative to the ENaC-
alone cells (Fig. 1C, top), suggest that CFTR inhibits ENaC
activity, as previously reported. In support, inhibiting CFTR
with compound 172 in the ENaC+CFTR cells in the absence
of amiloride partially restores ENaC activity (not shown).
Thus, one possible explanation for our results is that ENaC (at
least partially) inactivated by CFTR is stabilized at the plasma
membrane. Such stabilization of inactive/low activity channels
prevents excessive Na+ loading. This is in agreement with our
recent work, which suggests that cell-surface ENaC levels are
highly dependent on ENaC activity. Indeed, we find that the
stability of ENaC at the plasma membrane is greater in the
presence of amiloride (which inhibits ENaC activity) than in
its absence (not shown), likely due to the ability of cells to
tolerate more ENaCs that are inactive and cannot overload the
cell with Na+.
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